The COVIDTrach prospective cohort study on outcomes in 1982 tracheostomised COVID-19 patients during the first and second UK pandemic waves
Haywood M. et al, (2025), Scientific Reports, 15
ctDNA to Predict Treatment Response in Head and Neck Squamous Cell Carcinoma: A Systematic Review.
Jones O. et al, (2025), Laryngoscope
Circulating tumour DNA to augment PET-CT in determining clinical outcome after head and neck cancer treatment:
Bola S. et al, (2025), European Journal of Cancer, 115626 - 115626
Clinical Factors Influencing the Compliance With National Head and Neck Cancer Targets in the United Kingdom: Results From a National Cohort Study
Lim AE. et al, (2025), Clinical Otolaryngology, 50, 739 - 750
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition - CORRIGENDUM.
Homer JJ. and Winter SC., (2025), J Laryngol Otol
Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer).
Williamson A. et al, (2025), J Natl Cancer Inst
Trends in Investigations for Suspected Head and Neck Carcinoma of the Unknown Primary: A HNCIG and IFHNOS International Survey of Practice
Williamson A. et al, (2025), Head and Neck, 47, 1478 - 1486
Investigating the requirement for nasogastric tube feeding following transoral robotic surgery for head and neck cancer in Oxford: a retrospective cohort study.
Jones O. et al, (2025), J Laryngol Otol, 1 - 17
Immunotherapy for locally advanced head and neck cancer
Kyzas P. et al, (2025), British Journal of Oral and Maxillofacial Surgery
Investigations for Suspected Head and Neck Squamous Cell Carcinoma of Unknown Primary (HNSCCUP): A National Cohort Study
Hardman JC. et al, (2025), Clinical Otolaryngology
The Use of Fluorescent Markers to Detect and Delineate Head and Neck Cancer: A Scoping Review
Srinivasan A. et al, (2024), Clinical Otolaryngology
Correction to: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial (BMC Cancer, (2024), 24, 1, (823), 10.1186/s12885-024-12470-9)
Nankivell P. et al, (2024), BMC Cancer, 24
Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study
Hardman JC. et al, (2024), Clinical Otolaryngology, 49, 604 - 620
UK Head and Neck Cancer Multidisciplinary Guidelines - lay summary for non-clinicians.
Homer JJ. et al, (2024), J Laryngol Otol, 138, S1 - S25
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition - CORRIGENDUM.
Homer JJ. and Winter SC., (2024), J Laryngol Otol
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition - ERRATUM.
Homer JJ. and Winter SC., (2024), J Laryngol Otol, 1 - 5
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition.
Homer JJ. and Winter SC., (2024), J Laryngol Otol, 138, S1 - S224
New robotic platform for transoral robotic surgery: an IDEAL stage 0 study
Arora A. et al, (2024), BMJ Surgery, Interventions, & Health Technologies, 6, e000181 - e000181
Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study.
Mehanna H. et al, (2024), Clin Cancer Res, 30, 356 - 367
Current management of xerostomia in head and neck cancer patients
Nathan C-AO. et al, (2023), American Journal of Otolaryngology, 44, 103867 - 103867